Clinical use and effectiveness of dolutegravir and lamivudine: a long-term, real-world, retrospective study.

In our real-world experience, virological suppression rates were high for treatment-experienced persons on dolutegravir/lamivudine; however, we identified subgroups with a higher risk of lack of effectiveness at M12, who may benefit from closer follow-ups.